GERN FY 2023 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$237,000-60.2% YoY

Gross Profit

$237,000100.0% margin

Operating Income

-$194M-81832.9% margin

Net Income

-$184M-77690.7% margin

EPS (Diluted)

$-0.32

Cash Flow

Operating Cash Flow

-$168M

Free Cash Flow

-$169M

Stock-Based Comp.

$19M

Balance Sheet

Total Assets

$394M

Total Liabilities

$146M

Stockholders' Equity

$248M

Cash & Equivalents

$70M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$237,000	$596,000	-60.2%
Gross Profit	$237,000	$596,000	-60.2%
Operating Income	-$194M	-$139M	-40.0%
Net Income	-$184M	-$142M	-29.8%